← Back to Clinical Trials
Recruiting NCT07444151

NCT07444151 Post-Stroke Fatigue Perception Study (ReFast)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07444151
Status Recruiting
Phase
Sponsor School of Health Sciences Geneva
Condition Post-stroke Fatigue
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-01-27
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-01-27 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to better understand fatigue after stroke. Many people feel ongoing tiredness months or years after a stroke. This fatigue may affect daily activities, work, and social life. It does not always improve with rest. This study aims to answer these questions: How do participants describe their fatigue? How strong and how often does it occur? How does it affect daily life and quality of life? What strategies do participants use to manage it? About 20 to 30 adults living in French-speaking Switzerland who have had a stroke will take part. Participants will: Complete one anonymous questionnaire online or on paper. Answer questions about their fatigue and daily life. Share their experience in their own words. The questionnaire takes about 15 to 20 minutes. There are no medical tests, treatments, or follow-up visits. Participation is voluntary. Participants may stop at any time. No names or identifying information are collected. The results may help health professionals better understand post-stroke fatigue and improve rehabilitation care.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Living in French-speaking Switzerland * Confirmed history of ischemic or hemorrhagic stroke * Self-reported fatigue attributed to stroke * Living in the community (not institutionalized) * Able to read and understand written French * Able to provide informed consent Exclusion Criteria: * Transient ischemic attack (TIA) without confirmed stroke * History of two or more strokes * Currently institutionalized (e.g., nursing home, long-term hospital care, rehabilitation center) * Fatigue primarily caused by another chronic medical condition (e.g., cancer, primary depression, multiple sclerosis) * Severe cognitive or communication impairment preventing independent completion of the questionnaire * Unable to understand written French

Contact & Investigator

Central Contact

Pierre Nicolo, PhD

✉ pierre.nicolo@hesge.ch

📞 +41079263543

Principal Investigator

Pierre Nicolo, PhD

PRINCIPAL INVESTIGATOR

HEdS

Frequently Asked Questions

Who can join the NCT07444151 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post-stroke Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07444151 currently recruiting?

Yes, NCT07444151 is actively recruiting participants. Contact the research team at pierre.nicolo@hesge.ch for enrollment information.

Where is the NCT07444151 trial being conducted?

This trial is being conducted at Carouge, Switzerland.

Who is sponsoring the NCT07444151 clinical trial?

NCT07444151 is sponsored by School of Health Sciences Geneva. The principal investigator is Pierre Nicolo, PhD at HEdS. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology